A targeted community program of vitamin D treatment to reduce hospital admissions for falls, fractures and other disorders
A randomised controlled placebo-controlled study to evaluate the effects of vitamin D treatment on reducing hospital admissions for falls, fractures and other disorders in elderly women
Professor RL Prince
660 participants
Feb 1, 2009
Interventional
Conditions
Summary
This is a nine-month randomised controlled study to evaluate the effects of vitamin D 150,000 IU per three months on risk of falling, serum vitamin D levels, mobility function and muscle strength in women aged 70 years and over at a community setting.
Eligibility
Inclusion Criteria4
- Females age over 70;
- a) Registered with a General Practitioner (GP) attached to the practices selected for the study or
- b) Registered with a General Practitioner and able to contact her General Practitioner in Perth;
- Likely to be able to attend their General Practitioner practice or Sir Charles Gairdner Hospital for four study visits over nine months.
Exclusion Criteria3
- Consuming a vitamin D supplement either in isolation or as part of a combination treatment of greater than 200 IU per day, eg. Actonel combi +D or Fosamax plus;
- A mini mental state score of less than 24;
- Individuals who in the investigators opinion would not be suitable for the study.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
150,000 IU vitamin D (cholecalciferol) taken orally as 3 capsules at three clinic visits three months apart; lifestyle advice on physical activity and calcium intake given at baseline through an information sheet administered by trained research assistants
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12609000748213